Risk factors for community acquired urinary tract infection caused by ESBI-producing bacteria

Journal, Indian Academy of Clinical Medicine

Volumn 11, Issue 4, 2010, Pages 271-276

  Mahesh, E ^a   Ramesh, D ^a   Indumathi, V A ^b   Mohd Wasim Khan, ^a   Kumar, Prithivi S ^a   Punith, K ^a  

^a M S RAMAIAH INSTITUTE OF TECHNOLOGY   (India)

^b Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM; BALLOON CATHETER; CHILD; CLINICAL TRIAL; DIABETES MELLITUS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING BACTERIA; FEMALE; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; OUTPATIENT CARE; RISK FACTOR; SEX DIFFERENCE; URINARY TRACT INFECTION; URINE CULTURE;

EID: 79551577537     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bradford PA. Extended-spectrum-beta-lactamases in the 21st century: characterisation, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
2. Fierer J, Guiney D. Extended-spectrum-beta-lactamases: a plague of plasmids. JAMA 1999; 281: 563-4.
3. Wiener J, Quinn JP, Bradford PA et al. Multiple antibioticresistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 563-4.
4. Cormican M, Morris D, Corbett-Feeney G, Flynn J. Extendedspectrum- beta-lactamase production and fluoroquinolone resistance in pathogens associated with communityacquired urinary tract infection. Diagn Microbiol Infect Dis 1998; 32: 317-9.
5. Daza R, Gutierrez J, Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with communityacquired urinary tract infections. Int J Antimicrob Agents 2001; 18: 211-5.
6. Hryniewicz K, Szczypa K, Sulikowska A et al. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 2001; 47: 773-80.
7. Lescure FX, Eveillard M, Douadi Y, Eb F. Communityacquired multiresistant bacteria: an emerging problem? J Hosp Infect 2001; 49: 149-51.
8. Calbo E, Romani V, Xercavins M et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum-beta-lactamases. J Antimicrob Chemother 2006; 57: 780-3.
9. Topaloglu R, Er I, Dogan BG et al. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol 2010; 25: 919-25.
10. Lee DS, Lee CB, Lee SJ. Prevalence and risk factors for extended-spectrum-beta-lactamase-producing uropathogens in patients with urinary tract infection.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA, 2006.
12. Kader AA, Kumar A. Prevalence and antimicrobial susceptibility of extended-spectrum-beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 2005; 25: 239-42.
13. Rodriguez-Bano J, Pascual A. Clinical significance of extended-spectrum-beta-lactamases. Expert Rev Anti Infect Ther 2008; 6: 671-83.
14. Ortega M, Marco F, Soriano A et al. Analysis of 4,758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 2009; 63: 568-74.
15. Rodriguez-Bano J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extendedspectrum- beta-lactamase-producing Escherichia coli in nonhospitalised patients. J Clin Microbiol 2004; 42: 1089-94.
16. Ena J, Arjona F, Martínez-Peinado C et al. Epidemiology of urinary tract infections caused by extended-spectrumbeta- lactamase-producing Escherichia coli. Urology 2006; 68 (6): 1169-74.
17. Tandé D, Jallot N, Bougoudogo F et al. Extended-spectrumbeta- lactamase-producing Enterobacteriaceae in a Malian orphanage. Emerg Infect Dis 2009; 15: 472-4.
18. Yilmaz E, Akalin H, Ozbey S et al. Risk factors in communityacquired/ onset urinary tract infections due to extendedspectrum- beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. J Chemother 2008; 20: 581-5.
19. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrumbeta- lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-9.
20. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008; 13: 1-11.